SCHEMBL1963404

SCHEMBL1963404

COCCn1c(=S)[nH]c(N)c(N)c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.51
HSD17B10 Q99714 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
POLB P06746 3/20 0.49
PKM P14618 2/20 0.49
MAPK1 P28482 1/20 0.48
KDM4E B2RXH2 3/20 0.47
GAA P10253 2/20 0.47
USP2 O75604 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
RXFP1 Q9HBX9 6/20 0.46
RAB9A P51151 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1947210 0.83 ALDH1A1 (0.44) ALDH1A1HSD17B10L3MBTL1POLBPKM
SCHEMBL1961909 0.77 ALDH1A1 (0.45) ALDH1A1HSD17B10L3MBTL1POLBPKM
SCHEMBL1958324 0.73 GAA (0.59) ALDH1A1HSD17B10L3MBTL1POLBPKM
SCHEMBL11285331 0.71 ALDH1A1 (0.48) ALDH1A1HSD17B10L3MBTL1POLBPKM
SCHEMBL1959860 0.70 ALDH1A1 (0.41) ALDH1A1HSD17B10L3MBTL1POLBPKM
SCHEMBL6510029 0.68 ALDH1A1 (0.46) ALDH1A1HSD17B10MAPK1USP2RXFP1
SCHEMBL9420341 0.68 ALDH1A1 (0.51) ALDH1A1HSD17B10L3MBTL1POLBPKM
SCHEMBL19788134 0.68 ALDH1A1 (0.51) ALDH1A1HSD17B10L3MBTL1POLBPKM
SCHEMBL1946807 0.67 MEN1 (0.56) ALDH1A1L3MBTL1POLBPKMKDM4E
SCHEMBL14936068 0.67 ALDH1A1 (0.50) ALDH1A1HSD17B10L3MBTL1POLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332541-A1 Use of thioxanthine derivatives as MPO inhibitors AstraZeneca AB (SE) 2011-06-15 EP disclosed